Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Bristol-Myers Squibb describes new taxanes

Aug. 19, 1997

VEGF RTK inhibitors in the pipeline at Zeneca

Aug. 18, 1997

Terrapin and Taiho sign development agreement for anticancer agent

Aug. 18, 1997

Xechem granted patent for paclitaxel isolation and purification method

Aug. 14, 1997

Paclitaxel combination therapy in lung cancer

Aug. 14, 1997

Taxotere cleared in four additional countries

Aug. 13, 1997

MMP inhibitors described by Agouron

Aug. 13, 1997

EntreMed and the National Cancer Institute sign letters of intent

Aug. 12, 1997

Oncormed allowed U.S. patent for BRCA1 gene

Aug. 11, 1997

Bristol-Myers Squibb acquires broad-spectrum antitumor agents

Aug. 11, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...